文献速递胃肠外科

单孔与多孔腹腔镜结肠癌根治术长期结局的倾向评分分析

Long-term outcomes of single-incision versus multiport laparoscopic colectomy for colon cancer: results of a propensity score-based analysis.
PubMed 文献 · Surg Endosc · 2021-02-26

本研究通过倾向评分1:1匹配263对患者,比较单孔腹腔镜结肠癌根治术(SILC)与多孔腹腔镜结肠癌根治术(MPLC)的短期和长期结局。结果显示两组仅手术时间存在显著差异,5年癌症特异性生存率和3年无病生存率在各病理分期均无显著差异,切口疝发生率亦无显著差异。结论认为SILC的围术期和肿瘤学结局与MPLC相当。

要点

  • SILC与MPLC的5年癌症特异性生存率和3年无病生存率在各病理分期均无显著差异。
  • 两组仅手术时间存在显著差异,其余短期结局无显著差异。
  • 切口疝发生率SILC组8.0% vs MPLC组6.5%,无显著差异。

核心结论

  • 单孔腹腔镜结肠癌根治术的围术期和肿瘤学结局与多孔腹腔镜结肠癌根治术相当。

研究设计与样本

  • 回顾性倾向评分匹配队列研究,从691例患者中1:1匹配263对,比较SILC与MPLC的短期和长期结局。

主要发现

  • 手术时间是两组间唯一存在显著差异的手术结局(p=0.0004)。
  • SILC组总体5年癌症特异性生存率为93.7%(95%CI 89.6-96.2)%,MPLC组为93.3%(95%CI 89.4-95.9)%,组间无显著差异(p=0.5278)。
  • SILC组总体3年无病生存率为94.0%(95%CI 90.2-96.4)%,MPLC组为93.2%(95%CI 89.4-95.7)%,组间无显著差异(p=0.2829)。
  • 切口疝发生率SILC组为8.0%(21例),MPLC组为6.5%(17例),无显著差异(p=0.6139)。

临床怎么用

  • 在符合条件的结肠癌患者中,SILC可作为与MPLC相当的微创手术选择,但需注意手术时间可能延长。

局限性

  • 本研究为回顾性分析,可能存在选择偏倚;样本来自单中心,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Long-term outcomes of single-incision laparoscopic colectomy (SILC) for colon cancer (CC), as practiced in real-world settings, especially in relation to disease stage, have not been established. We examined, retrospectively, both short- and long-term outcomes of SILC versus those of multiport laparoscopic colectomy (MPLC) performed for CC in a propensity-score-matched cohort. METHODS: The study involved 263 patient pairs matched 1:1 from among 691 patients who, between January 2008 and May 2014, underwent either SILC or MPLC for a primary solitary CC at our hospital. Short-term and long-term operative outcomes were compared between the two groups. RESULTS: Operation time was the only surgical outcome that varied significantly between the two groups (p = 0.0004). Overall 5-year cancer-specific survival (CSS) in the SILC group was 93.7 (95% CI 89.6-96.2)%, and CSS per pathological stage (I, II and III) was 98.5 (90.0-99.8)%, 96.0 (88.2-98.7)%, and 88.3 (79.6-93.6)%, respectively, whereas overall 5-year CSS in the MPLC group was 93.3 (89.4-95.9)%, and CSS per pathological stage was 100%, 95.4 (88.3-98.3)%, and 84.1 (74.1-90.8)% (p = 0.5278, 0.2679, 0.7666, and 0.9073), respectively. Overall 3-year disease-free survival (DFS) in the SILC group was 94.0 (90.2-96.4)%, and 3-year DFS per pathological stage was 98.6 (90.4-99.8)%, 90.1 (81.4-95.0)%, and 79.0 (69.4-86.2)%, respectively, whereas overall 3-year DFS in the MPLC group was 93.2 (89.4-95.7)%, and 3-year DFS per pathological disease stage was 100%, 94.5 (87.4-97.7)% and 75.5 (64.7-83.8)% (p = 0.2829, 0.7401, 0.4335 and 0.8518), respectively. Thus, oncological outcomes did not differ significantly between groups. Incisional hernia occurred in 21 (8.0%) SILC group patients and 17 (6.5%) MPLC group patients, without a significant between-group difference (p = 0.6139). CONCLUSION: Our data indicate that perioperative and oncological outcomes of SILC performed for CC are comparable to those of MPLC performed for CC.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Suzuki Y, Tei M, Wakasugi M, et al. Long-term outcomes of single-incision versus multiport laparoscopic colectomy for colon cancer: results of a propensity score-based analysis. Surg Endosc. 2021. PMID: 33638106. doi:10.1007/s00464-021-08367-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。